Transfusion-Related Acute Lung Injury (TRALI): A Canadian Blood Services Research and Development Symposium

Transfusion Medicine Reviews

Volumn 24, Issue 4, 2010, Pages 305-324

  Saidenberg, Elianna ^a,b,c,d   Petraszko, Tanya ^a,b,c,d   Semple, Elisabeth ^a,b,c,d   Branch, Donald R ^a,b,c,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c Cells for Life Cord Blood Institute   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; LEUKOCYTE ANTIBODY;

ACUTE LUNG INJURY; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL TRIAL; GEOGRAPHIC DISTRIBUTION; GRANULOCYTE TRANSFUSION; HEART SURGERY; HUMAN; LEUKOCYTE TRANSFUSION; LUNG INFILTRATE; NONCARDIOGENIC LUNG EDEMA; REVIEW; RISK FACTOR; RISK REDUCTION; THROMBOCYTE TRANSFUSION;

ACUTE LUNG INJURY; BLOOD BANKS; BLOOD SAFETY; BLOOD TRANSFUSION; CANADA; CONGRESSES AS TOPIC; FEMALE; GREAT BRITAIN; HUMANS; MALE; MODELS, THEORETICAL; NATIONAL HEALTH PROGRAMS; RESEARCH; TRANSPLANTATION IMMUNOLOGY; UNITED STATES;

EID: 77956802983     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2010.05.005     Document Type: Review

References (60)

1. http://www.fda.gov/cber/blood/fatal07.htm.
2. Geelhoed G.W., Bennett S.H. "Shock lung" resulting from perfusion of canine lungs with stored bank blood. Am Surg 1975, 41:661-682.
3. Palfi M., Berg S., Ernerudh J., et al. A randomized controlled trial of transfusion-related acute lung injury: Is plasma from multiparous blood donors dangerous?. Transfusion 2001, 41:317-322.
4. Silliman C.C., Paterson A.J., Dickey W.O., et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion 1997, 37:719-726.
5. Clark S.R., Ma A.C., Tavener S.A., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007, 13:463-469.
6. + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 2009, 119:2898-2913.
7. + regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 2008, 9:239-244.
8. Barnard R.D. Indiscriminate transfusion: A critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951, 51:2399-2402.
9. Brittingham T.E. Immunologic studies on leukocytes. Vox Sang 1957, 2:242-248.
10. Phillips E., Fleischner F.G. Pulmonary edema in the course of a blood transfusion without overloading the circulation. Dis Chest 1966, 50:619-623.
11. Ward H.N. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med 1970, 73:689-694.
12. Byrne J.P., Dixon J.A. Pulmonary edema following blood transfusion reaction. Arch Surg 1971, 102:91-94.
13. Thompson J.S., Severson C.D., Parmely M.J., et al. Pulmonary "hypersensitivity" reactions induced by transfusion of non-HL-A leukoagglutinins. N Engl J Med 1971, 284:1120-1125.
14. Kernoff P.B., Durrant I.J., Rizza C.R., Wright F.W. Severe allergic pulmonary oedema after plasma transfusion. Br J Haematol 1972, 23:777-781.
15. Wolf C.F., Canale V.C. Fatal pulmonary hypersensitivity reaction to HLA incompatible blood transfusion: Report of a case and review of the literature. Transfusion 1976, 16:135-140.
16. Andrews A.T., Zmijewski C.M., Bowman H.S., et al. Transfusion reaction with pulmonary infiltration associated with HL-A-specific leukocyte antibodies. Am J Clin Pathol 1976, 66:483-487.
17. Popovsky M.A., Abel M.D., Moore S.B. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983, 128:185-189.
18. Popovsky M.A., Moore S.B. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985, 25:573-577.
19. Kleinman S., Caulfield T., Chan P., et al. Toward an understanding of transfusion-related acute lung injury: Statement of a consensus panel. Transfusion 2004, 44:1774-1789.
20. MacLennan S., Lucas G., Brown C., et al. Prevalence of HLA and HNA antibodies in donors: Correlation with pregnancy and transfusion history. Vox Sang 2004, 87(Suppl 3):S2-S16.
21. Payne R. The development and persistence of leukoagglutinins in parous women. Blood 1962, 19:411-424.
22. Densmore T.L., Goodnough L.T., Ali S., et al. Prevalence of HLA sensitization in female apheresis donors. Transfusion 1999, 39:103-106.
23. Kopko P.M., Marshall C.S., MacKenzie M.R., et al. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA 2002, 287:1968-1971.
24. Messent M., Sullivan K., Keogh B.F., et al. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction. Anaesthesia 1992, 47:262-268.
25. Wright S.E., Snowden C.P., Athey S.C., et al. Acute lung injury after ruptured abdominal aortic aneurysm repair: The effect of excluding donations from females from the production of fresh frozen plasma. Crit Care Med 2008, 36:1796-1802.
26. Win N., Chapman C.E., Bowles K.M., et al. How much residual plasma may cause TRALI?. Transfus Med 2008, 18:276-280.
27. Holness L., Knippen M.A., Simmons L., et al. Fatalities caused by TRALI. Transfus Med Rev 2004, 18:184-188.
28. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., et al. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood 2003, 101:454-462.
29. Goldman M., Webert K.E., Arnold D.M., et al. Proceedings of a consensus conference: Towards an understanding of TRALI. Transfus Med Rev 2005, 19:2-31.
30. AABB Bulletin #06-07 Transfusion-related acute lung injury 2006, AABB, Bethesda, MD.
31. AABB Bulletin #05-09 Transfusion-related acute lung injury 2005, AABB, Bethesda, MD.
32. FDA Center for Biologics Evaluation and Research, Fatalities reported to FDA following blood collection and transfusion, Annual Summary for Fiscal Years 2005 and 2006 2007, Available at. http://www.fda.gov/cber/blood/fatal0506.htm.
33. Stainsby D., Jones H., Knowles S., et al. Serious hazards of transfusion, Annual Report 2004 Available at. http://www.shotuk.org/shotreport2004.pdf.
34. Chapman C.E., Stainsby D., Jones H., et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009, 49:440-452.
35. Eder A.F., Herron R., Strupp A., et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007, 47:599-607.
36. Kopko P., Silva M., Shulman I., et al. AABB survey of transfusion-related acute lung injury policies and practices in the United States. Transfusion 2007, 47:1679-1685.
37. Eder A.F., Dy B., Herron R., et al. Effective reduction of TRALI risk with plasma collected predominantly from male donors. Transfusion 2009, 49:45A. (Abstract S108-040D).
38. FDA Center for Biologics Evaluation and Research, Fatalities reported to FDA following blood collection and transfusion, Annual Summary for Fiscal Years 2008 Available at. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm113649.htm.
39. AABB Bulletin #07-03 Clarifications to the recommendations to reduce the risk of TRALI. AABB, Bethesda, MD 2007.
40. Triulzi D.J., Kleinman S., Kakaiya R.M., et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009, 49:1825-1835.
41. Keller-Stanislawski B., Reil A., Günay S., et al. Frequency and severity of transfusion-related acute lung injury German hemovigilance data (2006-2007). Vox Sang 2010, 98:70-77.
42. Middelburg R.A., Van Stein D., Briet E., et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: A systematic review. Transfusion 2008, 48:2167-2176.
43. Silliman C.C., Bjornsen A.J., Wyman T.H., et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003, 43:633-640.
44. Sachs U.J., Hattar K., Weissmann N., et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 2006, 107:1217-1219.
45. Sachs U.J., Wasel W., Reil A., et al. Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood 2009, 114:14.
46. Nishimura M., Hashimoto S., Takanashi M., et al. Role of anti-human leucocyte antigen class II alloantibody and monocytes in development of transfusion-related acute lung injury. Transfus Med 2007, 17:129-134.
47. Rodey G.E., Neylan J.F., Whelchel J.D., et al. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994, 39:272-280.
48. Reil A., Keller-Stanislawski B., Gunay S., et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008, 95:313-317.
49. Maslanka K., Michur H., Zupanska B., et al. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang 2007, 92:247-249.
50. Greinacher A., Wesche J., Hammer E., et al. Characterization of the human neutrophil alloantigen-3a. Nat Med 2009, 16:45-48.
51. Kao K.J., Scornik J.C., Riley W.J., et al. Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 1988, 21:115-124.
52. Saw C., Goldman M., Nickerson P., et al. Evidence of patient specific HLA antibodies in Canadian TRALI cases classifies by the 2004 Canadian consensus conference 2009, abstract S 107-040D.
53. Lin Y., Hannach B., Huang M., et al. TRALI prevention at Canadian Blood Services: The evolving process and its impact on TRALI cases in Canada 2009, abstract S 112-040D.
54. Looney M.R., Su X., Van Ziffle J.A., et al. Neutrophils and their Fcγ receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006, 116:1615-1623.
55. Silliman C.C., Voelkel N.F., Allard J.D., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin 1998, 101:1458-1467.
56. Seeger W., Schneider U., Kreusler B., et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990, 76:1438-1444.
57. Kelher M.R., Masuno T., Moore E.E., et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009, 113:2079-2087.
58. Looney M.R., Nguyen J.X., Hu Y., et al. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest 2009, 119:3450-3461.
59. Cherry T., Steciuk M., Reddy V.V., et al. Transfusion-related acute lung injury: Past, present, and future. Am J Clin Pathol 2008, 129:287-297.
60. Schneider R.C., Zapol W.M., Carvalho A.C. Platelet consumption and sequestration in severe acute respiratory failure. Am Rev Respir Dis 1980, 122:445-451.